Nippon India Nifty Pharma ETF · Regular · Growth
NAV
₹29.3403
as of 13 Nov 2026
Expense Ratio
—
see scheme documents
AUM
₹1,700 Cr
Lumpsum returns (CAGR)
- 1Y
- +26.24%
- 3Y
- +23.07%
- 5Y
- +16.26%
- Since Inception
- +14.20%
SIP returns (XIRR)
- 1Y
- +37.34%
- 3Y
- +20.25%
- 5Y
- +20.99%
- Since Inception
- +20.05%
What history actually did — last 5 years (Nov 2021 – Nov 2026)
A ₹5,000 monthly SIP for the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹5,00,492 today — ₹3,00,000 invested, 21.1% XIRR.
₹3,00,000
Invested
₹5,00,492
Value today
21.1%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹2,12,392 today (16.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2021 would still hold ₹16,23,431.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Nov 2021 – Nov 2026) (4 Jun 2024) would be ₹1,55,131 today (1.55×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised1.05
Sharpe Ratio
—
Alpha
—
Beta
1.10
Sortino
13.99%
Std Dev
-7.53%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Sept 2026Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Nippon India Nifty Pharma ETF · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
What this fund does
Nippon India Nifty Pharma ETF · Regular · Growth is an exchange-traded fund (ETF) that trades on stock exchanges like a regular share. It offers real-time pricing, low expense ratios, and the flexibility to buy and sell units throughout the trading day.
About This Fund
Nippon India Nifty Pharma ETF · Regular · Growth is a ETF mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 5 years. It manages assets worth ₹1,700 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY PHARMA TRI.
Who Should Invest?
- •Investors who want to follow an index at low cost and accept that the fund moves with it